Medication discontinuation after curative surgery for sporadic primary hyperparathyroidism

Area of Science:

• Endocrinology
• Surgical Oncology

Background:

• Primary hyperparathyroidism (PH) management is debated for minimally symptomatic cases.
• The impact of parathyroidectomy (Ptx) on medication use post-surgery is not well-established.

Purpose of the Study:

• To evaluate if successful Ptx leads to reduced medication use in patients with PH.
• To compare medication changes after Ptx versus thyroidectomy (Tx).

Main Methods:

• A comparative study of patients undergoing Ptx for PH versus Tx.
• Review of patient demographics, symptoms, comorbidities, and pre/postoperative medications.

Main Results:

• Ptx patients were older, more frequently male, and had higher symptom/comorbidity prevalence than Tx patients.
• Postoperative symptom improvement was observed in Ptx patients, even with minimal symptoms.
• Medication discontinuation or dose reduction occurred in 11% of Ptx patients versus 4% of Tx patients (P = .01).

Conclusions:

• Curative Ptx effectively improves numerous PH symptoms.
• Surgery can lead to beneficial reductions in medication use for PH-related symptoms.
• Routine review and adjustment of medications post-Ptx are recommended.